Welcome to EpilepsyU.com a social network dedicated to the epilepsy community

Share This Post

Childhood Epilepsy / Epilepsy

Childhood and Lifelong Epilepsy Linked to Human Herpesvirus

Childhood and Lifelong Epilepsy Linked to Human Herpesvirus

Epileptic seizures linked to common childhood viral infection…Could antiviral treatment prevent some cases of epilepsy?

SANTA BARBARA, CA (June 14, 2012) A ten-year NIH-funded study has determined that a third of infants with prolonged seizures and fever suffer from either a new or reactivated roseola virus infection. Roseola viruses are the cause of the common childhood rash, but can also cause limbic encephalitis, a condition that frequently progresses to epilepsy. Investigators discovered one of the roseola viruses, human herpesvirus-6B (HHV-6B) in the blood of 32% of 169 infants with prolonged seizures, a condition known as status epilepticus. They found HHV-7 (another roseola virus) in 7.1% of the patients, usually as a co-infection with HHV-6B.

The study strengthens the link between HHV-6B and mesial temporal lobe epilepsy. HHV-6B is the primary cause of limbic encephalitis in transplant patients and half of those cases go on to develop epilepsy within 3-5 years. Furthermore, several studies have found HHV-6B DNA at high levels in the brain tissue of patients with refractory epilepsy. “A clinical trial is urgently needed to determine if repeat seizures and some cases of temporal lobe epilepsy might be prevented using existing antiviral therapy,” said Kristin Loomis, executive director of the HHV-6 Foundation.

These viruses persist in the brain cells and can be activated during periods of immunosuppression or stress. HHV-6 and HHV-7 are spread via the saliva and nearly 100% of the population has been infected by early adulthood.

Do childhood viruses smolder and emerge later as full-blown epilepsy?

“It is possible that these patients harbor latent virus in the brain tissue that reactivates later in response to unknown triggers,” said Leon Epstein, MD, a pediatric neurologist at the Northwestern University Feinberg School of Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago. Dr. Epstein is the lead author of this new study published in the journalEpilepsia.

While febrile or fever–related seizures occur in 2-5% of infants, most of whom recover with no consequences, less is known about the outcome in children who suffer from the prolonged febrile seizures associated with HHV-6 or HHV-7. These children are still being followed and investigators expect that 30-40% of them will develop epilepsy within five years.

Would some infants with prolonged seizures benefit from antiviral treatment?

Currently infants with seizures are not tested for HHV-6B or HHV-7 and treatment consists of anti-seizure drugs. However, the authors expect clinical trials to be established as soon as more evidence is gathered. Transplant patients suffering with seizures from HHV-6 reactivation are routinely treated with antivirals and antiviral treatment is now common practice for symptomatic infants infected with a closely virus: cytomegalovirus or CMV (HHV-5). Infants who contract CMV from their mothers during pregnancy or shortly following birth can develop seizures and mental retardation as well as permanent losses in both hearing and vision. Antiviral therapy reduces neurological complications and seizures in these infants. The neurologists who conducted the study remain cautious about antiviral therapy. They note that the oral antiviral drug used to treat CMV infections, valganciclovir, can cause reversible neutropenia, a form of anemia; less toxic antivirals such as CMX001 are in the pipeline.

“HHV-6B can cause a strong cytokine response, and there is emerging data that inflammatory mechanisms may be involved in developing epilepsy after an insult such as a prolonged seizure,” explained, Shlomo Shinnar, MD, PhD, of Montefiore Medical Center and Albert Einstein College of Medicine, and principal investigator of the study, “So it is possible that anti-inflammatory treatment could benefit these patients whether or not HHV-6B is the cause of the prolonged seizure. This is an area that needs further research.

HHV-6B reactivation associated with cognitive impairment

Investigators will also be studying the roseola virus subset to determine if they develop cognitive problems in the years following the seizures. “We know that children and adults with temporal lobe epilepsy have cognitive problems. It will be interesting to see whether those who started out with an HHV-6B infection have more cognitive impairment down the road,” said Shinnar.

A study by Danielle Zerr, an infectious disease specialist at Seattle Children’s Hospital and the University of Washington, suggests that Shinnar may be on the right track. She reported last year that patients who reactivate with HHV-6B during a transplant procedure are far more likely to develop cognitive dysfunction or delirium. The declines were especially significant in areas of attention, processing speed, and concentration, as well as cognitive flexibility or the ability to operate with divided attention.

Children who develop seizures in response to these common viruses may harbor genes that cause them to be susceptible. A mutation in the SCN1A gene has been linked to several epilepsy conditions. Variants of another gene, IRF5, have been associated with active HHV-6A infections in multiple sclerosis patients.


Kristin Loomis,
Executive Director, HHV-6 Foundation
Santa Barbara, California
Phone: 805-969-1174


  • NINDS: http://www.ninds.nih.gov/disorders/febrile_seizures/detail_febrile_seizures.htm
  • Bien 2007: “Limbic Encephalitis as a precipitating event in adult onset temporal lobe epilepsy”
  • Dunin-Wasocicz 2010: “Successful antiepileptic drug withdrawal in infants with epilepsy and cytomegalovirus neuroinfection: Longitudinal study”
  • Hill 2012: “Cord-blood hematopoietic stem-cell transplantation confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis”
  • Suzuki 2007: “Epilepsy in patients with congenital cytomegalovirus infection”
  • Oliver 2012: “Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system”
  • Vandenbroeck 2010: “Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection”
  • Zerr 2011: “HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplant recipients”


Share This Post


  1. Where were you 54 years ago. I thought I was reading about my case from infancy to

    I know it wasn’t available at the time but it is great to see finally someone working
    on this unknown rythym of epilepsy and not think one is crazy.

    Thank you, thank you, thank you, from the bottom of my heart.

  2. Where were you 54 years ago. I thought I was reading about my case from infancy to

    I know it wasn’t available at the time but it is great to see finally someone working
    on this unknown rythym of epilepsy and not think one is crazy.

    Thank you, thank you, thank you, from the bottom of my heart.


Comments are now closed for this post.